For the temporary relief of minor allergy symptoms: Runny Nose • Sneezing • Nasal Congestion
ClearLife™ Allergy Relief Nasal Spray 0.68 fl.oz.(20ml)
$12.99
Description
ClearLife’s Benefits:
-
So effective, it comes with an empty bottle guarantee
-
Non-drowsy, non-jittery relief
-
Can be safely used on top of other allergy medicines to get FULL relief
-
Does not cause over-dryness of nose & mouth
-
Long-lasting relief of indoor and outdoor allergies
Uses: For the temporary relief of minor allergy symptoms: Runny Nose • Sneezing • Nasal Congestion
At first signs of symptoms: Adults and children 12 years and older: 2 sprays into each nostril every 1/2 to 1 hour until symptoms lessen, then continue with standard dosage. Do not exceed 48 sprays in 24 hours. Children 4 to 11 years: 1 spray into each nostril every 1/2 to 1 hour until symptoms lessen, then continue with standard dosage. Do not exceed 24 sprays in 24 hours. For children under 4 years, consult our health professional. Standard Dosage: Adults and children 12 years and older: 2 sprays into each nostril every 4 to 6 hours. Children 4 to 11 years: 1 spray into each nostril every 4 to 6 hours. For children under 4 years, consult your health professional.
Inactive Ingredients: Benzalkonium chloride, Disodium phosphate dihydrate, Isotonic sodium chloride solution, Sodium dihydrogen phosphate dihydrate
0.68 fluid ounces (20ml)
Ask a doctor before use if you have asthma. In rare cases broncho-spasm may occur in asthmatic patients. Temporary burning, stinging, sneezing, or increased nasal discharge may occur. If pregnant or breast-feeding, ask a healthcare provider before use. The use of this dispenser by more than one person may spread infection. If symptoms persist or worsen, a healthcare provider should be consulted. Do not use if known sensitivity to ClearLife or any of its ingredients exists.
Disclaimer
These statements have not been evaluated by the FDA. These products are not intended to diagnose, treat, cure, or prevent any disease.
Reviews
There are no reviews yet.